Product
Testosterone Enanthate
Aliases
Andro LA, delatestryl, Delatestryl, Everone, testosterone enanthate (1 other aliases)
Name
TESTOSTERONE ENANTHATE
FDA Approved
Yes
5 clinical trials
3 organizations
1 drug
28 indications
2 documents
Indication
Spinal Cord InjuryIndication
Spinal Cord InjuriesIndication
TraumaIndication
Nervous SystemIndication
InjuriesIndication
Central Nervous System DiseasesIndication
Nervous System DiseasesIndication
Spinal Cord DiseasesIndication
Gonadal DisordersIndication
Endocrine System DiseasesIndication
HypogonadismIndication
Genital DiseasesIndication
maleIndication
Spinal Cord TraumaIndication
InjuryIndication
Spinal CordIndication
Gait AbnormalityIndication
DifficultyIndication
Gait DisordersIndication
NeurologicIndication
Movement DisorderIndication
Androgen DeficiencyIndication
Hormone DeficiencyIndication
Castration-Resistant Prostate CarcinomaIndication
Prostate CancerIndication
Facioscapulohumeral Muscular DystrophyIndication
Castration-resistant Prostate CancerIndication
HRDClinical trial
Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCIStatus: Terminated, Estimated PCD: 2021-08-13
Clinical trial
Locomotor Training With Testosterone to Promote Bone and Muscle HealthStatus: Recruiting, Estimated PCD: 2025-01-30
Clinical trial
Bipolar Androgen Therapy Plus Olaparib in Patient With Castration-Resistant Prostate CancerStatus: Completed, Estimated PCD: 2021-03-05
Clinical trial
Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept StudyStatus: Completed, Estimated PCD: 2022-03-28
Clinical trial
High Dose Testosterone + Carboplatin in Men With Advanced Prostate CancerStatus: Recruiting, Estimated PCD: 2024-12-30
Organization
Hikma Pharmaceuticals USA Inc.Organization
Eugia US LLCDocument
DailyMed Label: XYOSTEDOrganization
Antares Pharma, Inc.